BDRL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BDRL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Blonder Tongue Laboratories's interest expense for the three months ended in Dec. 2023 was $ -0.22 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.87 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Blonder Tongue Laboratories's Operating Income for the three months ended in Dec. 2023 was $ -0.34 Mil. Blonder Tongue Laboratories's Interest Expense for the three months ended in Dec. 2023 was $ -0.22 Mil. Blonder Tongue Laboratories did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Blonder Tongue Laboratories's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blonder Tongue Laboratories Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Interest Expense | Get a 7-Day Free Trial | -0.26 | -0.35 | -0.51 | -0.79 | -0.87 |
Blonder Tongue Laboratories Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Interest Expense | Get a 7-Day Free Trial | -0.24 | -0.23 | -0.21 | -0.21 | -0.22 |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blonder Tongue Laboratories (OTCPK:BDRL) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Blonder Tongue Laboratories's Interest Expense for the three months ended in Dec. 2023 was $-0.22 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-0.34 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $5.46 Mil.
Blonder Tongue Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as
Blonder Tongue Laboratories did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Williams James H /nj/ | director | C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN RD, OLD BRIDGE NJ 08857 |
Palle Robert J Jr | director, 10 percent owner, officer: President and COO | C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Eric S Skolnik | officer: Senior Vice President - CFO | C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
John E Burke | director | 1540 BARDSEY LANE, LOWER GWYNEDD PA 19002 |
Anthony J Bruno | director | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Cavalry Fund I Lp | 10 percent owner | 82 EAST ALLENDALE ROAD, SUITE 5B, SADDLE RIVER NJ 07458 |
Michael Hawkey | director | 2160 GOLD STREET, SAN JOSE CA 95002 |
Rick E Briggs | director | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Edward Rowland Grauch | officer: CEO & President | 3208 HIGHWAY 98, MEXICO BEACH FL 32456 |
Jeffrey W Smith | officer: Vice President - Sales | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Ronald Vincent Alterio | officer: VP-Engineering, CTO | C/O BLONDER TONGUE LABORATORIES, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Gary P Scharmett | director | |
Steven L Shea | director | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Stephen K Necessary | director | |
Bruce A Gureck | officer: Exec VP/COO | 4671 BOCAIRE BLVD, BOCA RATON FL 33487 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 03-14-2022
By ACCESSWIRE ACCESSWIRE • 08-12-2021
By ACCESSWIRE ACCESSWIRE • 03-31-2022
By ACCESSWIRE ACCESSWIRE • 02-11-2022
By ACCESSWIRE ACCESSWIRE • 04-29-2022
By ACCESSWIRE ACCESSWIRE • 11-04-2022
By ACCESSWIRE ACCESSWIRE • 10-29-2022
By ACCESSWIRE ACCESSWIRE • 12-11-2021
By ACCESSWIRE ACCESSWIRE • 05-23-2022
By ACCESSWIRE ACCESSWIRE • 10-25-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.